
Canada - TSX:CRH -
The current stock price of CRH.CA is 4.99 null. In the past month the price increased by 1.01%. In the past year, price increased by 78.21%.
CRH Medical Corp provides anesthesiology services to gastroenterologists in the United States through its subsidiaries and also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology.
CRH Medical Corp
999 Canada Place
Vancouver BC V6C 3E1
CEO: Tushar M. Ramani
Phone: +1 425 658-0151
CRH Medical Corp provides anesthesiology services to gastroenterologists in the United States through its subsidiaries and also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology.
The current stock price of CRH.CA is 4.99 null. The price increased by 0.4% in the last trading session.
CRH.CA does not pay a dividend.
CRH.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
You can find the ownership structure of CRH Medical Corp (CRH.CA) on the Ownership tab.
ChartMill assigns a technical rating of 8 / 10 to CRH.CA. When comparing the yearly performance of all stocks, CRH.CA is one of the better performing stocks in the market, outperforming 78.83% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to CRH.CA. Both the profitability and the financial health of CRH.CA get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months CRH.CA reported a non-GAAP Earnings per Share(EPS) of -0.342. The EPS decreased by -757.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -23.05% | ||
| ROA | -12.76% | ||
| ROE | N/A | ||
| Debt/Equity | 1.31 |